133 related articles for article (PubMed ID: 33503372)
1. Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection.
Zhang Q; Fu C; Guo X; Gao J; Zhang P; Ding C
ACS Sens; 2021 Mar; 6(3):1138-1146. PubMed ID: 33503372
[TBL] [Abstract][Full Text] [Related]
2. A ratiometric fluorescence probe based on carbon dots for discriminative and highly sensitive detection of acetylcholinesterase and butyrylcholinesterase in human whole blood.
Xu X; Cen Y; Xu G; Wei F; Shi M; Hu Q
Biosens Bioelectron; 2019 Apr; 131():232-236. PubMed ID: 30849722
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared ratiometric fluorescent strategy for butyrylcholinesterase activity and its application in the detection of pesticide residue in food samples and biological imaging.
Yuan W; Wan C; Zhang J; Li Q; Zhang P; Zheng K; Zhang Q; Ding C
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Sep; 297():122719. PubMed ID: 37043836
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
7. A turn-on fluorescent probe based on ESIPT and AIEE mechanisms for the detection of butyrylcholinesterase activity in living cells and in non-alcoholic fatty liver of zebrafish.
Pei X; Fang Y; Gu H; Zheng S; Bin X; Wang F; He M; Lu S; Chen X
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Feb; 287(Pt 1):122044. PubMed ID: 36327810
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
9. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation.
Yang Y; Cheng X; Liu W; Chou G; Wang Z; Wang C
J Ethnopharmacol; 2015 Jun; 168():279-86. PubMed ID: 25862961
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
11. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
12. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
13. Customized fluorescent probe for peering into the expression of butyrylcholinesterase in thyroid cancer.
Kang W; Ma M; Xu L; Tang S; Li J; Ma P; Song D; Sun Y
Anal Chim Acta; 2023 Nov; 1282():341932. PubMed ID: 37923409
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
15. Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase.
Pohanka M
Curr Med Chem; 2020; 27(18):2994-3011. PubMed ID: 30706778
[TBL] [Abstract][Full Text] [Related]
16. Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS.
Liu W; Yang Y; Cheng X; Gong C; Li S; He D; Yang L; Wang Z; Wang C
J Pharm Biomed Anal; 2014 Jun; 94():215-20. PubMed ID: 24631841
[TBL] [Abstract][Full Text] [Related]
17. Rational design of a near-infrared fluorescence probe for highly selective sensing butyrylcholinesterase (BChE) and its bioimaging applications in living cell.
Ma J; Lu X; Zhai H; Li Q; Qiao L; Guo Y
Talanta; 2020 Nov; 219():121278. PubMed ID: 32887168
[TBL] [Abstract][Full Text] [Related]
18. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
19. Dual-Mode Ratiometric Electrochemical and Turn-On Fluorescent Detection of Butyrylcholinesterase Utilizing a Single Probe for the Diagnosis of Alzheimer's Disease.
Dong H; Zhao L; Wang T; Chen Y; Hao W; Zhang Z; Hao Y; Zhang C; Wei X; Zhang Y; Zhou Y; Xu M
Anal Chem; 2023 May; 95(21):8340-8347. PubMed ID: 37192372
[TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
Jasiecki J; Wasąg B
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
